scPharmaceuticals Inc. (SCPH)
5.67
0.00 (0.00%)
Inactive · Last trade price on Oct 6, 2025
scPharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 49.97 | 36.33 | 13.59 | - | - | - | |
Revenue Growth | 107.79% | 167.28% | - | - | - | - |
Cost of Revenue | 15.76 | 11.36 | 3.81 | - | - | - |
Gross Profit | 34.21 | 24.97 | 9.78 | - | - | - |
Selling, General & Admin | 85.33 | 77.65 | 53.37 | 20.62 | 9.78 | 11.78 |
Research & Development | 15.42 | 12.1 | 11.81 | 15.53 | 16.04 | 18.15 |
Total Operating Expenses | 100.75 | 89.75 | 65.18 | 36.16 | 25.82 | 29.93 |
Operating Income | -66.54 | -64.78 | -55.4 | -36.16 | -25.82 | -29.93 |
Interest Income | 3.13 | 3.44 | 5.1 | 1.2 | 0.05 | 0.32 |
Interest Expense | -6.12 | -7.57 | -8.12 | -3.3 | -2.58 | -2.59 |
Other Non-Operating Income (Expense) | -9.15 | -16.25 | 3.61 | 1.42 | 0.32 | -0 |
Total Non-Operating Income (Expense) | -12.14 | -20.37 | 0.59 | -0.68 | -2.21 | -2.28 |
Pretax Income | -78.68 | -85.15 | -54.81 | -36.84 | -28.03 | -32.21 |
Net Income | -78.68 | -85.15 | -54.81 | -36.84 | -28.03 | -32.21 |
Net Income to Common | -91.72 | -85.15 | -54.81 | -36.84 | -28.03 | -32.21 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 52 | 45 | 39 | 28 | 27 | 25 |
Shares Outstanding (Diluted) | 52 | 45 | 39 | 28 | 27 | 25 |
Shares Change | 33.44% | 15.59% | 35.81% | 3.68% | 11.33% | 32.09% |
EPS (Basic) | -1.77 | -1.91 | -1.42 | -1.30 | -1.02 | -1.31 |
EPS (Diluted) | -1.77 | -1.91 | -1.42 | -1.30 | -1.02 | -1.31 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -65.86 | -70.56 | -59.28 | -34.6 | -27.16 | -27.69 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.27 | -1.58 | -1.54 | -1.22 | -0.99 | -1.13 |
Gross Margin | 68.46% | 68.73% | 71.96% | - | - | - |
Operating Margin | -133.16% | -178.29% | -407.53% | - | - | - |
Profit Margin | -157.47% | -234.36% | -403.22% | - | - | - |
FCF Margin | -131.80% | -194.21% | -436.14% | - | - | - |
EBITDA | -66.52 | -64.76 | -55.37 | -36.12 | -25.39 | -29.53 |
EBITDA Margin | -133.13% | -178.23% | -407.36% | - | - | - |
EBIT | -66.54 | -64.78 | -55.4 | -36.16 | -25.82 | -29.93 |
EBIT Margin | -133.16% | -178.29% | -407.53% | - | - | - |